The Osteoarthritis Market is expected to register a CAGR of 8.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Osteoarthritis Market report covers analysis by Treatment (Drugs, Assistive Devices); Disease (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis); End User (Hospital Pharmacies, Retail pharmacies, Drug Stores, E-commerce.), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Osteoarthritis Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Osteoarthritis Market Segmentation
Treatment- Drugs
- Assistive Devices
- Knee Osteoarthritis
- Spine Osteoarthritis
- Foot and Ankle Osteoarthritis
- Shoulder Osteoarthritis
- Hand Osteoarthritis
- Hospital Pharmacies
- Retail pharmacies
- Drug Stores
- E-commerce
Strategic Insights
Osteoarthritis Market Growth Drivers- Increasing elderly population: The aging population around the world drives the osteoarthritis market. The likelihood of osteoarthritis, a degenerative joint disease, grows significantly as the lifespan of an individual increases. Older adults are more vulnerable to conditions such as osteoarthritis, which primarily affects the weight-bearing joints of the body, including the knees, hips, and spine. This is contributing to the increase in demand for osteoarthritis treatments such as drugs, therapies, and surgery.
- Growing prevalence of obesity: Obesity is one of the major risk factors for osteoarthritis, especially in the knee joints. The increasing prevalence of obesity worldwide due to sedentary lifestyles, poor dietary habits, and limited physical activity is contributing to the increase in osteoarthritis cases. Excess body weight puts additional stress on joints, which worsens the condition. As the rate of obesity continues to rise, the demand for osteoarthritis treatments will also increase.
- Advancements in treatment options: Advances in medical research and technology have led to the development of new and more effective treatment options for osteoarthritis. These include targeted biologic therapies, regenerative treatments like platelet-rich plasma (PRP) and stem cell therapy, and novel drug formulations that can help manage symptoms more effectively. As these treatments become more available and accessible, they will likely drive the market growth.
- Shift toward non-surgical treatments: There is a growing trend toward non-surgical treatments for osteoarthritis, as many patients prefer non-invasive approaches that can relieve symptoms without the need for joint replacement surgery. Non-pharmacological options such as physical therapy, weight management programs, and lifestyle changes are becoming more popular, along with injectable treatments like hyaluronic acid, corticosteroids, and biologics. This trend is likely to continue, as many patients seek to avoid the risks and long recovery times associated with surgery.
- Increasing adoption of biologics and regenerative therapies: The biologics and regenerative therapies include stem cell injections, PRP therapy, and gene therapies. These are used to treat osteoarthritis and focus on repairing or regenerating damaged cartilage and joints. Biologic treatments can provide an alternative to drugs and surgeries. With more and more clinical evidence proving the efficacy and safety of these treatments, the adoption of biologic treatments is expected to grow rapidly and will be the major growth driver for the osteoarthritis market.
- Increase in demand for customized therapies: Personalized or precision medicine is becoming increasingly popular in the treatment of osteoarthritis, emphasizing tailoring therapy according to individual genetic profile, disease progression, and specific needs. Advancements in genomics, biomarkers, and diagnostics can help healthcare service providers provide more targeted treatment to patients with osteoarthritis. With this customization, patients are expected to experience better outcomes and drive market demand.
- Development of disease-modifying osteoarthritis drugs (DMOADs): Today, the primary thrust in osteoarthritis therapy remains symptomatic treatment, that is, managing the symptoms by relieving pain and inflammation. Still, an area of major potential is that of disease-modifying osteoarthritis drugs, or DMOADs, which slow down or halt disease progression, by addressing the etiology of cartilage loss. Development and marketing of such a drug would radically alter the face of osteoarthritis therapy, provide sustained long-term benefits for patients, and propel growth in the market.
- Research and development collaborative partnerships: Collaborations between pharmaceutical companies, research institutions, and biotechnology firms will be the future breakthroughs in osteoarthritis treatment. The pooling of resources and expertise will help accelerate the development of innovative therapies, including biologics, gene therapies, and new drug candidates. This also opens avenues for increasing the global reach of osteoarthritis treatments, which will enhance the growth potential of the market.
- Over-The-Counter (OTC) osteoarthritis pain relief: The increasing preference for OTC solutions to manage osteoarthritis symptoms, such as pain and inflammation, represents a growing opportunity in the market. Products like topical analgesics, NSAIDs, and natural supplements are becoming more widely available without prescription. As patients seek convenient, cost-effective treatment options, the OTC segment of the osteoarthritis market is poised for growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Osteoarthritis Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Osteoarthritis Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Osteoarthritis Market are Increasing elderly population, Growing prevalence of obesity, and Advancements in treatment options
The key future trends of the market are Shift toward non-surgical treatments, Increasing adoption of biologics and regenerative therapies, and Increase in demand for customized therapies
The leading players operating in the Osteoarthritis Market include Abbott Laboratories, Novartis AG, Pfizer, Inc, Abiogen Pharma Spa, Ampio Pharmaceuticals, BioDelivery Sciences International, Inc, Eli Lilly and Company, GlaxoSmithKline plc., Sanofi SA.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Osteoarthritis Market - By Treatment
1.3.2 Osteoarthritis Market - By Disease
1.3.3 Osteoarthritis Market - By End User
1.3.4 Osteoarthritis Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. OSTEOARTHRITIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSTEOARTHRITIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. OSTEOARTHRITIS MARKET - GLOBAL MARKET ANALYSIS
6.1. OSTEOARTHRITIS - GLOBAL MARKET OVERVIEW
6.2. OSTEOARTHRITIS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OSTEOARTHRITIS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. DRUGS
7.3.1. Overview
7.3.2. Drugs Market Forecast and Analysis
7.4. ASSISTIVE DEVICES
7.4.1. Overview
7.4.2. Assistive Devices Market Forecast and Analysis
8. OSTEOARTHRITIS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. KNEE OSTEOARTHRITIS
8.3.1. Overview
8.3.2. Knee Osteoarthritis Market Forecast and Analysis
8.4. SPINE OSTEOARTHRITIS
8.4.1. Overview
8.4.2. Spine Osteoarthritis Market Forecast and Analysis
8.5. FOOT AND ANKLE OSTEOARTHRITIS
8.5.1. Overview
8.5.2. Foot and Ankle Osteoarthritis Market Forecast and Analysis
8.6. SHOULDER OSTEOARTHRITIS
8.6.1. Overview
8.6.2. Shoulder Osteoarthritis Market Forecast and Analysis
8.7. HAND OSTEOARTHRITIS
8.7.1. Overview
8.7.2. Hand Osteoarthritis Market Forecast and Analysis
9. OSTEOARTHRITIS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail pharmacies Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. E-COMMERCE.
9.6.1. Overview
9.6.2. E-commerce. Market Forecast and Analysis
10. OSTEOARTHRITIS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Osteoarthritis Market Overview
10.1.2 North America Osteoarthritis Market Forecasts and Analysis
10.1.3 North America Osteoarthritis Market Forecasts and Analysis - By Treatment
10.1.4 North America Osteoarthritis Market Forecasts and Analysis - By Disease
10.1.5 North America Osteoarthritis Market Forecasts and Analysis - By End User
10.1.6 North America Osteoarthritis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Osteoarthritis Market
10.1.6.1.1 United States Osteoarthritis Market by Treatment
10.1.6.1.2 United States Osteoarthritis Market by Disease
10.1.6.1.3 United States Osteoarthritis Market by End User
10.1.6.2 Canada Osteoarthritis Market
10.1.6.2.1 Canada Osteoarthritis Market by Treatment
10.1.6.2.2 Canada Osteoarthritis Market by Disease
10.1.6.2.3 Canada Osteoarthritis Market by End User
10.1.6.3 Mexico Osteoarthritis Market
10.1.6.3.1 Mexico Osteoarthritis Market by Treatment
10.1.6.3.2 Mexico Osteoarthritis Market by Disease
10.1.6.3.3 Mexico Osteoarthritis Market by End User
10.1.6.4 US Osteoarthritis Market
10.1.6.4.1 US Osteoarthritis Market by Treatment
10.1.6.4.2 US Osteoarthritis Market by Disease
10.1.6.4.3 US Osteoarthritis Market by End User
10.2. EUROPE
10.2.1 Europe Osteoarthritis Market Overview
10.2.2 Europe Osteoarthritis Market Forecasts and Analysis
10.2.3 Europe Osteoarthritis Market Forecasts and Analysis - By Treatment
10.2.4 Europe Osteoarthritis Market Forecasts and Analysis - By Disease
10.2.5 Europe Osteoarthritis Market Forecasts and Analysis - By End User
10.2.6 Europe Osteoarthritis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Osteoarthritis Market
10.2.6.1.1 Germany Osteoarthritis Market by Treatment
10.2.6.1.2 Germany Osteoarthritis Market by Disease
10.2.6.1.3 Germany Osteoarthritis Market by End User
10.2.6.2 France Osteoarthritis Market
10.2.6.2.1 France Osteoarthritis Market by Treatment
10.2.6.2.2 France Osteoarthritis Market by Disease
10.2.6.2.3 France Osteoarthritis Market by End User
10.2.6.3 Italy Osteoarthritis Market
10.2.6.3.1 Italy Osteoarthritis Market by Treatment
10.2.6.3.2 Italy Osteoarthritis Market by Disease
10.2.6.3.3 Italy Osteoarthritis Market by End User
10.2.6.4 Spain Osteoarthritis Market
10.2.6.4.1 Spain Osteoarthritis Market by Treatment
10.2.6.4.2 Spain Osteoarthritis Market by Disease
10.2.6.4.3 Spain Osteoarthritis Market by End User
10.2.6.5 United Kingdom Osteoarthritis Market
10.2.6.5.1 United Kingdom Osteoarthritis Market by Treatment
10.2.6.5.2 United Kingdom Osteoarthritis Market by Disease
10.2.6.5.3 United Kingdom Osteoarthritis Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Osteoarthritis Market Overview
10.3.2 Asia-Pacific Osteoarthritis Market Forecasts and Analysis
10.3.3 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By Treatment
10.3.4 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By Disease
10.3.5 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Osteoarthritis Market
10.3.6.1.1 Australia Osteoarthritis Market by Treatment
10.3.6.1.2 Australia Osteoarthritis Market by Disease
10.3.6.1.3 Australia Osteoarthritis Market by End User
10.3.6.2 China Osteoarthritis Market
10.3.6.2.1 China Osteoarthritis Market by Treatment
10.3.6.2.2 China Osteoarthritis Market by Disease
10.3.6.2.3 China Osteoarthritis Market by End User
10.3.6.3 India Osteoarthritis Market
10.3.6.3.1 India Osteoarthritis Market by Treatment
10.3.6.3.2 India Osteoarthritis Market by Disease
10.3.6.3.3 India Osteoarthritis Market by End User
10.3.6.4 Japan Osteoarthritis Market
10.3.6.4.1 Japan Osteoarthritis Market by Treatment
10.3.6.4.2 Japan Osteoarthritis Market by Disease
10.3.6.4.3 Japan Osteoarthritis Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Osteoarthritis Market Overview
10.4.2 Middle East and Africa Osteoarthritis Market Forecasts and Analysis
10.4.3 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By Treatment
10.4.4 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By Disease
10.4.5 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Osteoarthritis Market
10.4.6.1.1 South Africa Osteoarthritis Market by Treatment
10.4.6.1.2 South Africa Osteoarthritis Market by Disease
10.4.6.1.3 South Africa Osteoarthritis Market by End User
10.4.6.2 Saudi Arabia Osteoarthritis Market
10.4.6.2.1 Saudi Arabia Osteoarthritis Market by Treatment
10.4.6.2.2 Saudi Arabia Osteoarthritis Market by Disease
10.4.6.2.3 Saudi Arabia Osteoarthritis Market by End User
10.4.6.3 U.A.E Osteoarthritis Market
10.4.6.3.1 U.A.E Osteoarthritis Market by Treatment
10.4.6.3.2 U.A.E Osteoarthritis Market by Disease
10.4.6.3.3 U.A.E Osteoarthritis Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Osteoarthritis Market Overview
10.5.2 South and Central America Osteoarthritis Market Forecasts and Analysis
10.5.3 South and Central America Osteoarthritis Market Forecasts and Analysis - By Treatment
10.5.4 South and Central America Osteoarthritis Market Forecasts and Analysis - By Disease
10.5.5 South and Central America Osteoarthritis Market Forecasts and Analysis - By End User
10.5.6 South and Central America Osteoarthritis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Osteoarthritis Market
10.5.6.1.1 Brazil Osteoarthritis Market by Treatment
10.5.6.1.2 Brazil Osteoarthritis Market by Disease
10.5.6.1.3 Brazil Osteoarthritis Market by End User
10.5.6.2 Argentina Osteoarthritis Market
10.5.6.2.1 Argentina Osteoarthritis Market by Treatment
10.5.6.2.2 Argentina Osteoarthritis Market by Disease
10.5.6.2.3 Argentina Osteoarthritis Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. OSTEOARTHRITIS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABIOGEN PHARMA SPA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMPIO PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIODELIVERY SCIENCES INTERNATIONAL, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILLY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GLAXOSMITHKLINE PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI SA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. STRYKER CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TER
- Abbott Laboratories
- Novartis AG
- Pfizer, Inc
- Abiogen Pharma Spa
- Ampio Pharmaceuticals
- BioDelivery Sciences International, Inc
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Sanofi SA
- Stryker Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For